MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Expert Opinion on Emerging Drugs
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

45 results · 1 filter active ·
Results by year
20012025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
45 works in the cohort · of 4,299,418page 1 of 1

Labels cover 0 of 45 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 45 of 45 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

afffundunlabeled
Emerging drugs in neuropathic pain
Ian Gilron, Terence J. Coderre
2007· review· en· Expert Opinion on Emerging Drugs· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
82
citations
afffundunlabeled
Emerging drugs for neuropathic pain
Ian Gilron, Anthony H. Dickenson
2014· review· en· Expert Opinion on Emerging Drugs· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
74
citations
affunlabeled
Emerging drugs for spinal cord injury
Darryl C. Baptiste, Michael G. Fehlings
2008· review· en· Expert Opinion on Emerging Drugs· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · metaepi_narrow
49
citations
affunlabeled
Emerging anti-inflammatory drugs for atherosclerosis
Jeremy Berman, Michael E. Farkouh, Robert S. Rosenson
2013· review· en· Expert Opinion on Emerging Drugs· Immunology and Microbiology
distilled prediction:candidate · metaepi_narrow+insufficient_payloadconsensus · none
35
citations
affunlabeled
Emerging drugs for major depressive disorder
Sidney H. Kennedy, Sakina J. Rizvi
2009· review· en· Expert Opinion on Emerging Drugs· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · metaepi_narrow
31
citations
affunlabeled
Emerging drugs for cystic fibrosis
Reshma Amin, Félix Ratjen
2014· review· en· Expert Opinion on Emerging Drugs· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
31
citations
affunlabeled
Emerging antidyslipidemic drugs
Rebecca L. Pollex, Tisha Joy, Robert A. Hegele
2008· review· en· Expert Opinion on Emerging Drugs· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
19
citations
affunlabeled
Emerging drugs for malignant glioma
Warren Mason
2008· review· en· Expert Opinion on Emerging Drugs· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
18
citations
affunlabeled
Use of cytokines in infection
Naoko Aoki, Zhou Xing
2004· review· en· Expert Opinion on Emerging Drugs· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
13
citations
affunlabeled
Emerging drugs for graft-versus-host disease
Natasha Kekre, Joseph H. Antin
2016· review· en· Expert Opinion on Emerging Drugs· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
11
citations
affunlabeled
Emerging drugs for levodopa-induced dyskinesia
Amaal Al Dakheel, Isabelle Beaulieu‐Boire, Susan H. Fox
2014· review· en· Expert Opinion on Emerging Drugs· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · metaepi_narrow
9
citations
affunlabeled
Emerging drugs for celiac disease
Hugh James Freeman
2014· review· en· Expert Opinion on Emerging Drugs· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
9
citations
affunlabeled
Emerging drugs for prostate cancer
Kashif Siddiqui, Laurence Klotz
2009· review· en· Expert Opinion on Emerging Drugs· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
8
citations
affunlabeled
Emerging drugs in the treatment of chronic cough
Danica Brister, Mustafaa Wahab, Moaaz Rashad, Nermin Diab, Martin Kolb, Imran Satia
2023· review· en· Expert Opinion on Emerging Drugs· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
8
citations
affunlabeled
Seltorexant for major depressive disorder
Kyle Valentino, Kayla M. Teopiz, Sabrina Wong, M Zhang, Gia Han Le, Hayun Choi +4 more
2025· review· en· Expert Opinion on Emerging Drugs· Neuroscience
distilled prediction:candidate · metaepi_narrowconsensus · none
3
citations
affunlabeled
The drug-based pipeline against restenosis
Pierre‐Frédéric Keller, Réda Ibrahim, Jean‐Claude Tardif
2005· review· en· Expert Opinion on Emerging Drugs· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
3
citations

How this was built: Screen · Findings · About